28036 Phase 2 randomized, placebo-controlled, dose-ranging study to evaluate the safety and efficacy of onabotulinumtoxina for the treatment of platysma prominence

Autor:	Joely Kaufman-Janette, Brian S. Biesman, Rodney J Rohrich, Shannon Humphrey, Warren Tong, Jason K. Rivers, David E. Bank, Channy Muhn, Derek K. Jones, Steven H. Dayan, Vince Bertucci
Rok vydání:	2021
Předmět:	business.industry Phase (matter) Anesthesia Medicine Dermatology Dose-ranging study Placebo business
Zdroj:	Journal of the American Academy of Dermatology. 85:AB171
ISSN:	0190-9622
DOI:	10.1016/j.jaad.2021.06.698
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d9a31b5707b4b5cc963c8f5262a630d3 https://doi.org/10.1016/j.jaad.2021.06.698 Zobrazit plný text záznamu Full Text from ScienceDirect